2m 2m 2m 2m 2m 2m 2m
Esperion Therap (ESPR)
NASDAQ
$3.19+$0.01 (+0.35%)
Price as of Jul 10, 2026 7:41 PM EDT- $819.5MMarket Cap
- 167.23%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Esperion Therap (ESPR)
$3.19+$0.01 (+0.35%)
ESPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.18 | ||
Change | -$0.010 (-0.31%) | ||
Open | $3.18 | ||
High | $3.19 | ||
Low | $3.18 | ||
Previous Close | $3.19 | ||
Volume | 59,089,990 | ||
30-Day Average Volume | 15,783,904 | ||
1-Week Change | 0.63% | ||
1-Month Change | 1.27% | ||
1-Year Change | 167.23% | ||
3-Year Change | 97.52% | ||
5-Year Change | -83.50% | ||
Fundamentals | |||
Shares Outstanding | 257.7M | ||
Total Assets | $462.5M | ||
Market Cap | $819.5M | ||
Enterprise Value | $913.4M | ||
Period: QTR TTM FY | |||
Revenue | $43.4M | ||
Net Income | -$25.2M | ||
Free Cash Flow | -$27.9M | ||
EBIT | -$20.9M | ||
EBITDA | -$20.9M | ||
Net Working Capital | $159.1M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -44 | ||
Enterprise Value/Revenue | 21 | ||
P/B | -3 | ||
P/E | -32 | ||
PEG | 0 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 06/11/2013 | ||
Earnings & Revenue